Highlights Bioretec Oy

Equities

BRETEC

FI4000480454

Delayed Nasdaq Helsinki Other stock markets 04:05:12 2024-04-30 am EDT			5-day change	1st Jan Change
2.54 ^EUR	-3.42%		-7.64%	+5.83%

Apr. 05	Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	CI
Mar. 22	Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	Mar. 22	MT
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition	Mar. 21	CI
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage	Mar. 14	CI
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2	Mar. 11	MT
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation	Mar. 08	CI
Bioretec Estimates the Approval of the European Market Authorization for the Biodegradable RemeOs? Trauma Screw Will Move to the First Quarter of 2024	23-10-18	CI
Bioretec Secures Distribution Agreement for Trauma Screws in US Market	23-09-12	MT
Bioretec Signs Distribution Deal for Launch of Orthopedic Product in US	23-09-12	MT
Bioretec Ltd. Enters into the U.S. Distribution Agreement with Spartan Medical Inc. for the RemeOs Screws	23-09-12	CI
Bioretec Wins R&D Grant from Business Finland for Developing Advanced Biodegradable Implants	23-09-06	MT
Bioretec Ltd Acquires New CNC Machining Center to Increase Production Capacity of RemeOs Products at its Factory in Tampere, Finland	23-06-13	CI
Bioretec Ltd, Receives U.S. Market Authorization for Its RemeOs Trauma Screw from the U.S. Food and Drug Administration	23-04-24	CI
Bioretec Wins US FDA Nod for Bioresorbable Orthopedic Implant	23-03-30	MT
Bioretec Ltd Receives Market Authorization of the U.S. Food and Drug Administration for Its Pioneering Remeos Traversed with the Clinical Trial	23-03-30	CI
Bioretec Submits Additional Data Requested By US FDA For Trauma Screw	23-01-03	MT
Bioretec Ltd Submits Additional Information Requested by the FDA for US Registration of RemeOs Trauma Screws	23-01-03	CI
Bioretec Ltd, Updates Estimate of U.S. registration of RemeOs™ Screws and Expects Approval in April 2023	22-10-14	CI
Bioretec Secures European Patent for Composite Material With Medical Applications	22-09-08	MT
Bioretec's Hybrid Composite Patent Has Been Approved in Europe	22-09-08	CI
Bioretec Ltd Announces Bioresorbable Activa IM-Nail™ Shows Convincing Results in Post-Market Clinical Follow Up Study for the Treatment of Children's Forearm Fractures	22-06-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bioretec Oy

Equities

BRETEC

FI4000480454

Highlights

Filters